The impact of estrogen receptor β gene polymorphisms on the atherogenic index and coronary artery disease in Iraqi population.

Q4 Medicine

Wiadomosci lekarskie Pub Date : 2025-01-01 DOI:10.36740/WLek/199561

Rasha Farhood Medlool, Karar Nadhum Obaid Aljabry, Majid Kadhum Hussain

{"title":"The impact of estrogen receptor β gene polymorphisms on the atherogenic index and coronary artery disease in Iraqi population.","authors":"Rasha Farhood Medlool, Karar Nadhum Obaid Aljabry, Majid Kadhum Hussain","doi":"10.36740/WLek/199561","DOIUrl":null,"url":null,"abstract":"Objective: Aim: To study the impact of the estrogen receptor beta polymorphisms rs4986938 (AluI) and rs1256049 (RsaI) on ischemic heart disease as well as the atherogenic index in Iraqi population.Patients and methods: Materials and Methods: A case-control research study was conducted on a sample of Coronary artery disease patients in addition to a group of normal individuals. Serum lipid concentrations were measured in the participants, and the ER gene (rs1256049, rs4986938) was genotyped by PCR- RFLP.Results: Results: Atherogenic serum lipid concentrations increased significantly in Coronary artery disease patients relative to the control group. Genotyping of the estrogen receptor β gene forrs4986938 SNP revealed a significant (OR=2.79, P=0.000) elevation of the GA genotype carriers in Coronary artery disease versus the control groups. The genotype analysis of thers1256049 SNP failed to exhibit a significant variation. Atherogenic index and serum lipid concentration markedly elevated with these polymorphisms.Conclusion: Conclusions: The polymorphisms of ESRβ rs4986938, (not for rs1256049) was associated with risk of Coronary artery disease and implicated in changes of serum lipid concentrations and atherogenic index in Iraqi population. Additional studies of ESRβ genetic variation and risk of CVD are warranted.","PeriodicalId":23643,"journal":{"name":"Wiadomosci lekarskie","volume":"78 1","pages":"148-155"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wiadomosci lekarskie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36740/WLek/199561","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Aim: To study the impact of the estrogen receptor beta polymorphisms rs4986938 (AluI) and rs1256049 (RsaI) on ischemic heart disease as well as the atherogenic index in Iraqi population.

Patients and methods: Materials and Methods: A case-control research study was conducted on a sample of Coronary artery disease patients in addition to a group of normal individuals. Serum lipid concentrations were measured in the participants, and the ER gene (rs1256049, rs4986938) was genotyped by PCR- RFLP.

Results: Results: Atherogenic serum lipid concentrations increased significantly in Coronary artery disease patients relative to the control group. Genotyping of the estrogen receptor β gene forrs4986938 SNP revealed a significant (OR=2.79, P=0.000) elevation of the GA genotype carriers in Coronary artery disease versus the control groups. The genotype analysis of thers1256049 SNP failed to exhibit a significant variation. Atherogenic index and serum lipid concentration markedly elevated with these polymorphisms.

Conclusion: Conclusions: The polymorphisms of ESRβ rs4986938, (not for rs1256049) was associated with risk of Coronary artery disease and implicated in changes of serum lipid concentrations and atherogenic index in Iraqi population. Additional studies of ESRβ genetic variation and risk of CVD are warranted.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Wiadomosci lekarskie Medicine-Medicine (all)

CiteScore

0.80

自引率

0.00%

发文量

482